Aptevo Therapeutics APVO Slips 143 as Shares Test Key Support Near 466 Healthcare and Tech Lead SP 500 Higher Utilities Slump Forrester Research Q1 2026 Earnings EPS Misses Estimates by Wide Margin Shares Edge Higher Gold Rebound Signals Market Shift to Slower US Growth Expectations